HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers

This article was originally published in The Tan Sheet

Executive Summary

FDA's head of regulatory affairs' Aug. 17 message to staff about cancelling plans to close seven field labs did not mark the end of the agency's ORA reorganization work, staff members say

You may also be interested in...



E&C investigation

The House Energy and Commerce Subcommittee on Oversight and Investigations announces Aug. 24 it is investigating FDA's plan to outsource jobs. Energy and Commerce Chairman John Dingell, D-Mich., and Subcommittee Chair Bart Stupak, D-Mich., say in a release they were "incredulous" when they learned of FDA's plan to outsource 332 positions. The news comes one week after Dingell and Stupak commended the Office of Regulatory Affairs' plan to shut down seven labs (1"The Tan Sheet" Aug. 27, 2007, p. 6). The congressmen are asking for a list of the positions as well as descriptions of job responsibilities, records reflecting the plans, budget analyses and more by Sept. 7...

FDA Reconsiders ORA Reorganization As Questions From Congress Continue

FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics

Appropriators Boost FDA Budget For Food Safety While Opposing Lab Closings

House and Senate appropriators make it known in reports on FDA's fiscal 2008 appropriation that they question the agency's plan to close more than half of its field labs, with the House bill specifically banning funding for the reorganization

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS138246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel